Sort
15,273 grants matching “antimicrobial resistance”
Sexually Transmitted Infections Clinical Trial Group: Clinical Study of Point-of-Care Diagnostics
$608,815Jeffrey Klausner · Social And Scientific Systems, Inc. · N01 · FY2020 · AI
Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci
$608,362Mohamed Seleem · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · AI
Determining How a Dynamic Microbiome Contributes to Cystic Fibrosis Lung Disease
$608,280Robert Andrew Quinn · Michigan State University · R01 · FY2022 · AI
Containing Bioterroist and Emerging Infectious Diseases
$608,262Emory University · U01 · FY2004 · GM
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
$608,245Marjana Tomic-Canic · University Of Miami School Of Medicine · R01 · FY2023 · DK
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$607,999Joshua William Schaeffer · Colorado State University · R01 · FY2023 · OH
Selenium Coated Dialysis Catheters for Reduced Biofilm Formation
$607,977Eric J Tobin · Spire Corporation · R44 · FY2008 · DK
Poor Treatment Response and Outcomes in Bedaquiline-Based Treatment Regimens for Drug-Resistant Tuberculosis in South Africa
$607,835Yuri F. Van Der Heijden · Vanderbilt University Medical Center · R01 · FY2021 · AI
Regulatory Role of Tandem Tryptophan Codons in Chlamydial Persistence
$607,417Reynaldo A Carabeo · University Of Nebraska Medical Center · R01 · FY2021 · AI
Regulatory Role of Tandem Tryptophan Codons in Chlamydial Persistence
$607,417Reynaldo A Carabeo · University Of Nebraska Medical Center · R01 · FY2023 · AI
Cathelicidin in Skin Immunity
$607,167Richard L Gallo · University Of California, San Diego · R37 · FY2025 · AI
Angiogenic and anti-microbial supports for pulp regeneration
$606,909Vivek Kumar · New Jersey Institute Of Technology · R01 · FY2023 · DE
METABOLIC SIGNATURES OF ANTIMICROBIAL RESISTANCE
$606,694George Mason University · · FY2016 · Defense Threat Reduction Agency
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$606,542Molly A Hughes · University Of Virginia · R01 · FY2022 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$606,446Angelica Cifuentes Kottkamp · New York University School Of Medicine · UM1 · FY2025 · AI
Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
$606,296Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Using gonococcal TonB-dependent transporters as vaccine antigens
$605,931Cynthia Nau Cornelissen · Georgia State University · U19 · FY2023 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$605,629Jerrold J. Ellner · Boston Medical Center · U01 · FY2014 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$605,604Jerrold J. Ellner · Boston Medical Center · U01 · FY2015 · AI
Antimicrobial evaluation and development
$605,549Kim Lewis · Northeastern University · P01 · FY2018 · AI
Task X10: Preclinical Services for the Development of Therapeutics against Antimicrobial Resistant Organisms
$605,471Jon Mirsalis · Sri International · N01 · FY2016 · AI
BIOCHEMISTRY OF BACTERIAL CELL MEMBRANES
$605,383University Of California Berkeley · R01 · FY2003 · AI
Novel biofilm polymicrobial infection-resistant implants for otologic application
$605,267Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2010 · DC
Antibiotic dereplication by transcriptome analysis
$605,144Karen E. Nelson · Northeastern University · P01 · FY2020 · AI
Role of Molecular Chaperones in Stress Response and Disease
$605,085Ursula H Jakob · University Of Michigan At Ann Arbor · R35 · FY2017 · GM